Linzess 145 MCG capsule UU 30S
Ended Awarded
- Contract number
- SPE2DR26FHY9M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,418
Award facts
- Contract value 100% obligated
- $4,417.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LINZESS 145 MCG capsules (30-count units) on November 6, 2025, with a contract ceiling value of $4,417.98. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's portfolio encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The LINZESS delivery—a gastrointestinal medication—represents routine pharmaceutical supply operations supporting the Defense Health Agency and other federal healthcare customers. The broader SPE2DX contract vehicle enables flexible procurement of pharmaceutical products to support military healthcare programs globally, with DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards among multiple contractors.
Quick answers
Who was awarded contract SPE2DR26FHY9M?
SPE2DR26FHY9M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FHY9M worth?
The government has obligated $4,418 on SPE2DR26FHY9M.
Is contract SPE2DR26FHY9M an order under another contract?
Yes. SPE2DR26FHY9M is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FHY9M competed?
The extent of competition for SPE2DR26FHY9M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award